[HTML] springer.comFull View

[HTML][HTML] Combination of blockade of endothelin signalling and compensation of IGF1 expression protects the retina from degeneration

N Shigesada, N Shikada, M Shirai, M Toriyama… - Cellular and Molecular …, 2024 - Springer
Retinitis pigmentosa (RP) and macular dystrophy (MD) cause severe retinal dysfunction,
affecting 1 in 4000 people worldwide. This disease is currently assumed to be intractable …
被引用次数：1 相关文章
[HTML] nih.gov

[HTML][HTML] Combination of blockade of endothelin signalling and compensation of IGF1 expression protects the retina from degeneration

N Shigesada, N Shikada, M Shirai… - … and Molecular Life …, 2024 - ncbi.nlm.nih.gov
Retinitis pigmentosa (RP) and macular dystrophy (MD) cause severe retinal dysfunction,
affecting 1 in 4000 people worldwide. This disease is currently assumed to be intractable …

Combination of blockade of endothelin signalling and compensation of IGF1 expression protects the retina from degeneration

N Shigesada, N Shikada, M Shirai… - … and molecular life …, 2024 - pubmed.ncbi.nlm.nih.gov
Retinitis pigmentosa (RP) and macular dystrophy (MD) cause severe retinal dysfunction,
affecting 1 in 4000 people worldwide. This disease is currently assumed to be intractable …

Combination of blockade of endothelin signalling and compensation of IGF1 expression protects the retina from degeneration.

N Shigesada, N Shikada, M Shirai… - … and Molecular Life …, 2024 - europepmc.org
Retinitis pigmentosa (RP) and macular dystrophy (MD) cause severe retinal dysfunction,
affecting 1 in 4000 people worldwide. This disease is currently assumed to be intractable …

[引用][C] Combination of blockade of endothelin signalling and compensation of IGF1 expression protects the retina from degeneration

N Shigesada, N Shikada, M Shirai… - … and Molecular Life …, 2024 - europepmc.org
Retinitis pigmentosa (RP) and macular dystrophy (MD) cause severe retinal dysfunction,
affecting 1 in 4000 people worldwide. This disease is currently assumed to be intractable …